Tenax Therapeutics, Inc.
TENX· Nasdaq
TENXTenax Therapeutics, Inc.
Filed Mar 16, 2017 · 10-K · 75 days after period end · 0001654954-17-002098
derived · Computed from the longer spans the company filed.
| Metric | Q4 2016dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|---|
| Revenue | — | $95.49K | — |
| Net Income | -$47.48M | -$2.61M | $2.85M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tenax Therapeutics, Inc. · CIK 34956 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Mar 16, 2017 · 75 d after period end
